L9A-23246-93482
2 vaccinations
4 coded responses
20 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 940 / CA
- Registered
- 2022-07-05
- Relationship
- Child or adolescent in my care
- Guardian
- SK6-31421-54094
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-05
Registered in v-safe
-
2022-07-05
Dose 1 — Moderna
- 2022-07-05
- 2022-07-06
-
2022-07-07
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-07-08
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Mood altered — Feeling: Fair · FeverFree text: SubduedMedDRA releases: 2024-11 · check-in free text available
- 2022-07-09
-
2022-07-12
Survey response — day 7, dose 1, under 3MedDRA: Hand-foot-and-mouth disease — Feeling: Fair · Fever · Irritability/crying, Loss of appetite, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolFree text: Hand foot mouth diseaseMedDRA releases: 2024-11 · check-in free text available
- 2022-07-20
- 2022-07-27
-
2022-08-02
Dose 2 — ModernaCo-administered: MMR
- 2022-08-02
-
2022-08-04
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/crying, Diarrhea · Be unable to work or attend schoolUnder 3 check-in
-
2022-08-05
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolUnder 3 check-in
-
2022-08-06
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolUnder 3 check-in
-
2022-08-07
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolUnder 3 check-in
- 2022-08-11
- 2022-08-18
- 2022-08-31
- 2022-09-08
- 2022-09-13
-
2022-11-03
Survey response — 3 months, dose 2, under 3MedDRA: Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fever but NAAT says not covidMedDRA releases: 2024-11 · check-in free text available
-
2023-01-31
Survey response — 6 months, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-05 | Moderna | No |
| 2 | 2022-08-02 | Moderna | MMR |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Subdued
Release 12 (Under 3) — day 7, dose 1, under 3
Systemic reaction (other): Hand foot mouth disease
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Fever but NAAT says not covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Hand-foot-and-mouth disease | · | · | ✓ |
| SRO | Mood altered | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release